THORNTON JOSEPH CLAY sold $110K of CLOV
THORNTON JOSEPH CLAY (Chief Financial Officer) sold 22,099 shares of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) at $4.97 ($0.11M total) on 2026-11-16.
How this was made
The 30-second read
Why it matters
The only new information is the CFO’s open-market sale details (shares, price, total value, and post-transaction holdings).
Market read
Traders may briefly reassess sentiment around CLOV due to insider selling, but the filing does not provide a fundamental driver.
What to watch
No 10b5-1 plan is cited, but the filing alone does not reveal the insider’s cost basis, tax considerations, or whether other planned sales occurred.
Background
The article is an SEC Form 4 insider transaction disclosure for Clover Health Investments, Corp. (CLOV).
Ticker impact
Clover Health CFO Thornton Joseph Clay sold 22,099 shares at $4.97 on 2026-11-16, per a new SEC Form 4 filing.
Likely limited near-term pressure as traders weigh the sale against broader fundamentals.
The disclosure is a routine Form 4 insider transaction with no stated 10b5-1 plan and no accompanying operational or guidance change.
Market effects
Minimal, as this is company-specific insider selling with no sector-wide signal.
None indicated.
None indicated.
Counterpoint
The sale could be routine liquidity management and does not necessarily reflect bearish expectations, especially without evidence of a broader change in fundamentals.
Key entities
- issuerCLOVER HEALTH INVESTMENTS, CORP. /DE
US-listed company whose CFO filed the insider sale on Form 4.
- insiderTHORNTON JOSEPH CLAY
Clover Health CFO who sold shares in an open-market transaction.



